Copy
Anatara e-news 02/07/15
View this email in your browser

Anatara presents to the
Philadelphia Securities Association


Last month, Anatara's Chief Executive Officer, Dr Paul Schober, was invited to present a company and technology overview to members of the prestigious Philadelphia Securities Association.

Medify Daily features Anatara 


Anatara has featured in Medify Daily, a news and resource provider for the biotech, health and medical industries in Australia and New Zealand.

"Anatara starts new scour trial, woos BIO"

Please click here to read the full article >>

Anatara in the news


Anatara received further media coverage last week on the back of its recent announcements and positive share price.
  • Proactiveinvestors - "Anatara Lifesciences developing non-antibiotic gastrointestinal treatments26/06/15
  • The Land - "Detach's second trial" 25/06/15 (see below)

Dr Paul Schober
CEO

Bioshares Biotech Summit (Queenstown, New Zealand) July 17-18

The summit will provide an opportunity to showcase Anatara to existing and potential fund managers and retail investors.

For more information, please click here. 
 
All data and information provided in this newsletter is for informational purposes only. Anatara Lifesciences makes no representations as to accuracy, completeness, currentness, suitability, or validity of any information on this site and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages arising from its display or use. All information is provided on an as-is basis.


Copyright © 2015 Anatara Lifesciences Ltd, All rights reserved.


unsubscribe from this list    update subscription preferences